Apr 12, 2024

Poster awards announced!

Awards were conferred for posters exhibited at the 2024 AAD Annual Meeting in San Diego.

Adam Friedman, MD, FAAD“With a record-setting number of abstracts this year, our work group had its ‘work’ cut out and therefore we expanded to meet the vast and diverse volume of incredible projects and cases submitted,” said the Poster Exhibit Chair, Adam Friedman, MD, FAAD. “Intellectual productivity is clearly plentiful, practical, and innovative guidance/data that was accessible during the 2024 AAD Annual Meeting and can be used to support our patients, colleagues, and community."

1st Place Winner:

Poster ID# 51363
Poster Abstract Title: Growth Analysis in Children Aged Less Than 12 Years with Moderate-to-Severe Atopic Dermatitis
Primary Author: Amy S. Paller, MD, FAAD
Primary Author Email: [email protected]
Institution: Northwestern University Feinberg School of Medicine

2nd Place Winner:

Poster ID# 54414
Poster Abstract Title: Effect of maternal hidradenitis suppurativa on offspring outcomes
Primary Author: Kaiyang Li, BSc
Primary Author Email: [email protected]
Institution: Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada

3rd Place Winner:

Poster ID#: 53329
Poster Abstract Title: Long-Term Adverse Event Risks of Systemic Janus Kinase (JAK) Inhibitors versus Traditional Immunomodulators
Primary Author: Olivia Lamberg, BS
Primary Author Email: [email protected]
Institution: University of Michigan Medical School

4th Place Winner:

Poster ID#: 50804
Poster Abstract Title: Low-Dose Oral Minoxidil Initiation and Monitoring (LOMI) For Hair Loss: A Modified Delphi Consensus of Experts
Primary Author: Yagiz Matthew Akiska, BSE
Primary Author Email: [email protected]
Institution: Department of Dermatology, University of California, San Francisco & George Washington University, School of Medicine and Health Sciences

Honorable Mention:

Poster ID#: 51977
Poster Abstract Title: Classification and Grading of Dermatologic Adverse Events from Anti-Cancer Therapies: A Multi-Center Study of Dermatology and Medical Oncology Physicians
Primary Author: Christopher Fay, BA
Primary Author Email: [email protected]
Institution: Department of Dermatology, Brigham and Women's Hospital, and the Center for Cutaneous Oncology, Dana-Farber/Brigham Cancer Center, Harvard Medical School; Boston, MA